About Diagnostech

Diagnostech, established in 2005, has been the sole distributor for Dako, an Agilent Technologies Company, in Southern Africa for over a decade, with our territory now including more than 34 African countries. Agilent Technologies Inc. acquired Dako in 2012, and through this acquisition, Diagnostech became the official sole distributor for Agilent Genomics and Diagnostic solutions, including Dako Pathology and Flow Cytometry Solutions in South Africa. In 2018, Diagnostech further expanded our portfolio to include product offerings from HistoCyte Laboratories and Lucigen. Our extensive portfolio includes, but is by no means limited to:

  • Immunohistochemistry (IHC)
  • Companion Diagnostics (pharmDx)
  • Molecular Pathology
  • Flow Cytometry
  • H&E and Special Stains
  • Controls

  • Microarray Technology
  • Next Generation Sequencing (NGS)
  • PCR, RT-PCR and qPCR
  • Mutagenesis
  • Cloning Vectors and Reagents
  • Enzymes
  • DNA/RNA Purification
  • Protein Expression
  • Competent Cells
  • Synthetic Biology
Our vision and mission

Diagnostech is built on three strong foundational core values: Ethics, Service and Doing things properly. We do not take shortcuts, nor do we undervalue our offering by doing half a job. It is through respect for our colleagues and clients alike that we endeavour to do our best every day and to live our core value of service through resiliency, excellence and care.

About Agilent Technologies

Agilent Technologies Inc. (NYSE: A) a global leader in life sciences, diagnostics and applied chemical markets is the premier laboratory partner for a better world. The company provides laboratories worldwide with instruments, services, consumables, applications and expertise, enabling customers to gain the insights they seek. Agilent’s expertise and trusted collaboration give customers the highest confidence in their solutions.

About HistoCyte Laboratories

HistoCyte Laboratories Ltd founders, Dr Ian Milton and Colin Tristram, share over 30 years of experience in the development of diagnostic products. Their novel technology allows them to produce and process cell lines into tissue-like controls manufactured to a reproducible standard and inexhaustible supply. Their aim is to deliver this cost-effective control material to laboratories looking to improve confidence in their results and ultimately the service they offer.

About Lucigen

Lucigen Corporation is working to improve people’s lives by providing quality products and services to life science and healthcare professionals. Founded in Wisconsin in 1998, Lucigen offers products and services that enable life-science professionals to perform their research and testing more efficiently and effectively. Core competencies include enzyme evolution, protein expression, cloning, competent cells, next-gen sequencing, and molecular diagnostics.